Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mallinckrodt Plc (MNK)

Mallinckrodt Plc (MNK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mallinckrodt Plc COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH BLANCHARDSTOWN DUBLIN 15 L2 D15 IRL

www.mallinckrodt.com P: 353-1696-0000

Description:

Mallinckrodt Plc. develops, produces, markets and distributes specialty pharmaceutical products and therapies. The company offers branded pharmaceutical products for autoimmune and rare diseases in specialty areas such as rheumatology, nephrology, neurology, pulmonology and ophthalmology. It also offers immunotherapy, oncology and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. Mallinckrodt Plc. is headquartered in Dublin, Ireland.

Key Statistics

Overview:

Market Capitalization, $K 4,481
Enterprise Value, $K 2,666,781
Shares Outstanding, K 13,171
Annual Sales, $ 1,914 M
Annual Net Income, $ -911,200 K
Last Quarter Sales, $ 475,000 K
Last Quarter Net Income, $ -747,800 K
EBIT, $ -421,100 K
% of Insider Shareholders 3.14%
Float, K 12,757
% Float 96.86%
Short Volume Ratio 0.37

Growth:

1-Year Return -96.91%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -40.58%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.45 on 08/09/23
Latest Earnings Date 08/08/23
Earnings Per Share ttm 9.55
EPS Growth vs. Prev Qtr -186.31%
EPS Growth vs. Prev Year 1.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MNK Ratios

Ratio
Price/Earnings ttm 0.04
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 20.32%
Return-on-Assets % 2.49%
Profit Margin % -47.60%
Debt/Equity 1.18
Price/Sales 0.00
Price/Cash Flow N/A
Price/Book 0.01
Book Value/Share 47.49
Interest Coverage -2.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar